Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection.
The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation.,
American Journal of Clinical Pathology
Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis
Bone Marrow Transplantation
Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.
Biol. Blood Marrow Transplant., Aug;18(8):1174-81 (2012)
Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.
Biol. Blood Marrow Transplant., Aug;18(8):1281-6 (2012)
Durable donor engraftment after radioimmunotherapy using Î±-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
Blood., Feb;119(5):1130-8 (2012)
Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.
Transplantation., Dec;92(12):1301-8 (2011)
Inhibition of IL-32 activation by Î±-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.
Blood., Nov;118(18):5031-9 (2011)
Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.
Biol. Blood Marrow Transplant., Jan;18(1):84-91 (2012)
Long-term regulation of genetically modified primary hematopoietic cells in dogs.
Mol. Ther., Jul;19(7):1287-94 (2011)
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
Biol. Blood Marrow Transplant., Mar;16(3):311-9 (2010)
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
Biol. Blood Marrow Transplant., Dec;15(12):1513-22 (2009)
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.
Biol. Blood Marrow Transplant., Oct;15(10):1244-50 (2009)
Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model.
Exp. Hematol., Oct;37(10):1157-66 (2009)
Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
Biol. Blood Marrow Transplant., Nov;14(11):1201-8 (2008)
High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector.
J. Clin. Invest., Apr;118(4):1502-10 (2008)
Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
Blood., Jul;110(1):418-23 (2007)
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biol. Blood Marrow Transplant., Mar;13(3):355-65 (2007)